Corticosteroid treatment for acute/acute-on-chronic experimental and naturally occurring pancreatitis in several species: a scoping review to inform possible use in dogs
Open Access
- 13 July 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Acta Veterinaria Scandinavica
- Vol. 63 (1), 1-34
- https://doi.org/10.1186/s13028-021-00592-0
Abstract
Acute pancreatitis in dogs is a prevalent disease characterised by mild to severe inflammation. Treatment with anti-inflammatory corticosteroids has been widely debated but is not generally recommended in veterinary medicine. The objective of the present study was to present current evidence on the effect of corticosteroid treatment for acute/acute-on-chronic pancreatitis across species. These findings were then used to evaluate if and how corticosteroid treatment could influence disease outcome in canine acute/acute-on-chronic pancreatitis. A scoping review was performed by searching the Agricola, CAB Abstracts, MEDLINE and Embase databases to identify relevant articles published before June 24, 2021. The inclusion criteria were English language, original research published in a peer-reviewed journal, and investigation of corticosteroid treatment effects on acute/acute-on-chronic pancreatitis by the outcome parameters clinical score, circulating CRP level, hospitalisation duration, mortality and pancreas histopathology. Research on any species was considered. Studies were rated based on the level of evidence, and methodological quality was evaluated based on similarity between groups at baseline, risk of bias and study group size. The reporting method was based on the PRISMA extension for scoping reviews. One thousand nine hundred fifty-four studies were identified, and 31 met the inclusion criteria. Five were canine studies, with 4 investigating experimentally induced pancreatitis; 5 were human clinical studies; and 21 were rodent studies of experimentally induced pancreatitis. The level of evidence ranged between randomised controlled trials and case series, the estimated risk of bias ranged from low to high, and the sample sizes ranged from very small to moderate. Evidence indicates that adding corticosteroid to symptomatic treatment of acute/acute-on-chronic canine pancreatitis could have a positive influence on disease outcome. However, the analysed evidence was based on several species, including both naturally occurring and experimentally induced pancreatitis; thus, the authors suggest that large randomised controlled studies should be performed in dogs with spontaneously occurring acute/acute-on-chronic pancreatitis to further elucidate a potential benefit of corticosteroid treatment.Keywords
This publication has 92 references indexed in Scilit:
- Chronic pancreatitis in dogs: A retrospective study of clinical, clinicopathological, and histopathological findings in 61 casesThe Veterinary Journal, 2013
- Effects of dexamethasone and Salvia miltiorrhiza on multiple organs in rats with severe acute pancreatitisJournal of Zhejiang University-SCIENCE B, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Sensitivity and Specificity of Canine Pancreas‐Specific Lipase (cPL) and Other Markers for Pancreatitis in 70 Dogs with and without Histopathologic Evidence of PancreatitisJournal of Veterinary Internal Medicine, 2011
- Critical illness-related corticosteroid insufficiency in patients with severe acute biliary pancreatitis: a prospective cohort studyCritical Care, 2009
- Prevalence and breed distribution of chronic pancreatitis at post‐mortem examination in first‐opinion dogsJournal of Small Animal Practice, 2007
- Relative Adrenal Insufficiency in Dogs with SepsisJournal of Veterinary Internal Medicine, 2007
- Influence of Hydrocortisone, Prednisolone, and NO Association on the Evolution of Acute PancreatitisDigestive Diseases and Sciences, 2006
- C‐reactive protein concentrations in canine acute pancreatitisJournal of Veterinary Emergency and Critical Care, 2004